| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |